[Podcast] The Omicron variant: Where are we now, and what is the future for testing?

Matthew Hittle, Mario Luis Ramirez
Akin Gump Strauss Hauer & Feld LLP
Contact
LinkedIn
Facebook
X
Send
Embed

Akin Gump Strauss Hauer & Feld LLP

Download PDF

In this episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Dr. Michael Mina, chief science officer for eMed, a digital point-of-care platform.

Among the topics covered:

  • The Omicron variant and prospects for 2022.
  • The future of COVID testing.
  • Biden-Harris administration plans regarding testing.
  • Rapid tests and reporting.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akin Gump Strauss Hauer & Feld LLP | Attorney Advertising

Written by:

Akin Gump Strauss Hauer & Feld LLP
Akin Gump Strauss Hauer & Feld LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Akin Gump Strauss Hauer & Feld LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide